AIDS-related peripheral/systemic lymphoma
Showing 1 - 25 of >10,000
AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell
Completed
- AIDS-related Diffuse Large Cell Lymphoma
- +8 more
- cyclophosphamide
- +7 more
-
Eldoret, Kenya
- +1 more
Sep 12, 2022
AIDS-Related Burkitt Lymphoma, AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Plasmablastic Lymphoma Trial run by the
Active, not recruiting
- AIDS-Related Burkitt Lymphoma
- +5 more
- Prednisone
- +7 more
-
Bethesda, MarylandNCI Lymphoid Malignancies Branch
Jul 31, 2022
AIDS-related Non-Hodgkin Lymphoma, AIDS-related Plasmablastic Lymphoma, AIDS-related Primary Effusion Lymphoma Trial in Duarte
Active, not recruiting
- AIDS-related Non-Hodgkin Lymphoma
- +3 more
- busulfan
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
AIDS Related Lymphoma and Lympholeukemia Trial in Hangzhou (ThisCART19A)
Recruiting
- AIDS Related Lymphoma and Lympholeukemia
- ThisCART19A
-
Hangzhou, Zhejiang, ChinaThe first affiliated hospital of medical college of zhejiang uni
Apr 17, 2022
Collecting Blood and Tissue Sample Donations for Research for
Not yet recruiting
- Anal Carcinoma
- +11 more
- Biospecimen Collection
- (no location specified)
Dec 21, 2022
Tool to Describe HIV-Related Cancer Burden and Patient
Not yet recruiting
- HIV-Associated Malignant Neoplasm
- +7 more
- Non-Interventional
- Non-Interventional Follow-up
- (no location specified)
Aug 18, 2022
AIDS Related Lymphoma, AIDS-Associated Lymphoma Trial run by the NCI (Filgrastim, Rituximab, EPOCH)
Completed
- AIDS Related Lymphoma
- AIDS-Associated Lymphoma
- Filgrastim
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 18, 2022
Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Boston (Microdevices, Standard of care therapy, Standard of care
Recruiting
- Cutaneous T Cell Lymphoma
- Peripheral T Cell Lymphoma
- Microdevices
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jul 16, 2022
AIDS-related Lymphoma, HIV Trial in Hamburg (PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC))
Terminated
- AIDS-related Lymphoma
- HIV Infections
- PBSC-M87o, Gene (M87o)-modified, CD34+ peripheral blood progenitor cells (PBSC)
-
Hamburg, GermanyUniversity Medical Center Hamburg-Eppendorf
Sep 4, 2022
Lymphoma, AIDS-related, Lymphoma, Large B-Cell, Diffuse Trial run by the NCI (Rituximab, Filgrastim, EPOCH)
Active, not recruiting
- Lymphoma, AIDS-related
- Lymphoma, Large B-Cell, Diffuse
- Rituximab
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 21, 2022
Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Enteropathy-Associated T-Cell Lymphoma, Recurrent Follicular T-Cell
Recruiting
- Recurrent Angioimmunoblastic T-Cell Lymphoma
- +13 more
- Brentuximab Vedotin
- Pembrolizumab
-
Chicago, IllinoisNorthwestern University
Jun 15, 2022
Clinical and Genomic Factors for Prognosis of AIDS Primary
Recruiting
- AIDS-Related Primary Effusion Lymphoma
- Laboratory Biomarker Analysis
- Medical Chart Review
-
La Jolla, California
- +5 more
Jan 21, 2022
Lymphoma, Non-Hodgkin, HIV Trial in New Orleans (Methotrexate, Leucovorin calcium, Zidovudine)
Terminated
- Lymphoma, Non-Hodgkin
- HIV Infections
- Methotrexate
- +3 more
-
New Orleans, LouisianaTulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU
Oct 27, 2021
AIDS Related Lymphoma, HIV Related Lymphoma Trial in Worldwide
Recruiting
- AIDS Related Lymphoma
- HIV Related Lymphoma
-
Munich, Select One Option, Germany
- +5 more
Jan 28, 2022
Diffuse Large Cell Lymphoma, Non-Hodgkin Lymphoma, Burkitt Lymphoma Trial run by the National Cancer Institute (NCI)
Recruiting
- Diffuse Large Cell Lymphoma
- +4 more
- Vincristine
- +6 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail
Recruiting
- T-cell Lymphoma
- +30 more
- Optional Blood Sample
- Optional Nail Sample
-
Duarte, California
- +25 more
Jul 28, 2023
Cutaneous T-Cell Lymphoma/Mycosis Fungoides Trial in Fairport (Hypericin)
Completed
- Cutaneous T-Cell Lymphoma/Mycosis Fungoides
-
Fairport, New YorkRochester Skin Lymphoma Medical Group
Aug 24, 2022
Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))
Not yet recruiting
- Leukemia
- +12 more
- Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
- (no location specified)
Mar 20, 2023
People Living With HIV Treated With CD19-directed CAR T Cell
Active, not recruiting
- Leukemia
- +9 more
-
Philadelphia, PennsylvaniaPennsylvania Hospital
Mar 29, 2023
Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,
Terminated
- Acute Biphenotypic Leukemia
- +29 more
- Cyclophosphamide
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 4, 2023
HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,
Recruiting
- HIV Infection
- +10 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
La Jolla, California
- +3 more
Dec 7, 2022
AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Non-Hodgkin Lymphoma, HIV Infection Trial (Axicabtagene Ciloleucel,
Not yet recruiting
- AIDS-Related Diffuse Large B-cell Lymphoma
- +14 more
- Axicabtagene Ciloleucel
- +2 more
- (no location specified)
Feb 15, 2022
Epstein-Barr Virus (EBV) Infections, Lymphoproliferative Disorders, EBV+ Associated Lymphoma Trial (tabelecleucel)
Available
- Epstein-Barr Virus (EBV) Infections
- +11 more
- tabelecleucel
- (no location specified)
Feb 15, 2022
Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial
Active, not recruiting
- Acute Leukemia
- +14 more
- Busulfan
- +10 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 18, 2022
Malignant Diseases (ie, Leukemia, MDS, Lymphoma), Non-malignant Diseases (ie, Bone Marrow Failure Syndromes) Trial in Milwaukee
Completed
- Malignant Diseases (ie, Leukemia, MDS, Lymphoma)
- Non-malignant Diseases (ie, Bone Marrow Failure Syndromes)
- CliniMACS (CD+3, CD+19 depletion)
- +2 more
-
Milwaukee, WisconsinChildren's Hospital of Wisconsin
Oct 21, 2021